Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Patient Participation × Dermatologic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 13 Gastrointestinal 11 Genitourinary 5 Thoracic 4 Lymphoid 4 Other hematologic neoplasm 3 Plasma cell 2 Head & Neck 2 Sarcoma 1 Other neoplasm 1 Gynecologic 1 Endocrine 1 Dermatologic 1 Classical hematology 1 CNS 1

Conditions

Melanoma 2805 Skin Neoplasms 499 Lymphoma, T-Cell, Cutaneous 487 Carcinoma, Non-Small-Cell Lung 368 Neoplasms 342 Mycosis Fungoides 332 Breast Neoplasms 316 Carcinoma, Basal Cell 314 Keratosis, Actinic 308 Sezary Syndrome 298 Lymphoma, Non-Hodgkin 278 Carcinoma, Renal Cell 270 Lymphoma 269 Neoplasm Metastasis 264 Leukemia, Lymphocytic, Chronic, B-Cell 258 Lymphoma, Large B-Cell, Diffuse 253 Lymphoma, Follicular 251 Uveal Melanoma 244 Hodgkin Disease 241 Lymphoma, Mantle-Cell 240 Precursor Cell Lymphoblastic Leukemia-Lymphoma 239 Lymphoma, B-Cell, Marginal Zone 239 Burkitt Lymphoma 228 Lymphoma, Large-Cell, Immunoblastic 223 Lung Neoplasms 203 Colorectal Neoplasms 199 Ovarian Neoplasms 189 Lymphoma, Large-Cell, Anaplastic 182 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 176 Multiple Myeloma 176

Interventions

Decision Support Techniques 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04240717 2022-11-07

PEF-Immun

University Hospital Heidelberg

Phase NA Completed

Melanoma, Patient Participation

Data powered by HemOnc (CC BY 4.0) Colophon ⚡